ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

GSK Gsk Plc

1,653.00
12.50 (0.76%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Gsk Plc GSK London Acción Ordinaria
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
12.50 0.76% 1,653.00 10:35:15
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1,638.50 1,634.00 1,655.50 1,653.00 1,640.50
más cotizaciones de acciones »
Sector Industrial de la empresa
PHARMACEUTICALS & BIOTECHNOLOGY

Noticias Recientes

Fecha Hora Fuente Noticia
24/4/202403:14ALNCNewsGSK's Jemperli with chemotherapy accepted for priority..
24/4/202401:00UK RNSGSK PLC US FDA accepts new indication filing for Jemperli
19/4/202409:30UK RNSGSK PLC Director/PDMR Shareholding
17/4/202409:30UK RNSGSK PLC Director/PDMR Shareholding
17/4/202402:46ALNCNewsTOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea..
17/4/202401:05UK RNSGSK PLC GSK announces additional EAGLE-1 results
17/4/202401:00UK RNSGSK PLC Results from long-term data relating to Shingrix
16/4/202408:11UK RNSGSK PLC Amendment - Director/PDMR Shareholding
16/4/202402:59ALNCNewsGSK's latest meningitis vaccine accepted for review by US..
16/4/202401:00UK RNSGSK PLC FDA accepts GSK meningitis vaccine candidate file
15/4/202409:30UK RNSGSK PLC Director/PDMR Shareholding
08/4/202404:27ALNCNewsIN THE KNOW: Barclays ups GSK price target but HIV drug..
04/4/202406:05UK RNSGSK PLC Replacement - Total Voting Rights
02/4/202409:00UK RNSGSK PLC Total Voting Rights
26/3/202410:30UK RNSGSK PLC Director/PDMR Shareholding
25/3/202408:00UK RNSGSK PLC Notice of AGM
22/3/202411:20UK RNSGSK PLC Transfer of Treasury Shares
22/3/202410:36UK RNSGSK PLC Director/PDMR Shareholding
18/3/202404:30UK RNSGSK PLC New Phase III Jemperli data in endometrial cancer
18/3/202403:47ALNCNewsGSK says Jemperli combination gets good results for..
13/3/202410:48UK RNSGSK PLC Director/PDMR Shareholding
08/3/202411:12UK RNSGSK PLC Board Committee Change
07/3/202403:38ALNCNewsGSK observes positive data in Blenrep trial for blood cancer..
07/3/202401:00UK RNSGSK PLC GSK announces positive Blenrep DREAMM-8 results
06/3/202410:00UK RNSGSK PLC ViiV LAI vs oral SOC data in adherence-challenged
05/3/202411:24UK RNSGSK PLC GSK Annual Report 2023 on Form 20-F
05/3/202405:03ALNCNewsGSK says ViiV's cabotegravir study supports longer HIV dose..
05/3/202401:00UK RNSGSK PLC New ViiV LA formulation potential 4-month dosing
01/3/202409:00UK RNSGSK PLC Total Voting Rights
01/3/202406:15UK RNSGSK PLC GSK publishes Annual Report 2023
29/2/202403:44ALNCNewsTOP NEWS: GSK avoids "protracted litigation" with Zantac..
29/2/202401:05UK RNSGSK PLC Directorate Change
29/2/202401:00UK RNSGSK PLC Statement: Zantac (ranitidine) litigation
26/2/202409:30UK RNSGSK PLC Director/PDMR Shareholding
26/2/202402:25ALNCNewsGSK gonorrhoea treatment achieves efficacy endpoint in..
26/2/202401:00UK RNSGSK PLC GSK announces positive EAGLE-1 headline results
22/2/202409:30UK RNSGSK PLC Director/PDMR Shareholding
21/2/202403:47ALNCNewsGSK reports encouraging results for ViiV's Cabenuva HIV..
21/2/202401:00UK RNSGSK PLC ViiV LAI superior to orals in adherence-challenged
20/2/202403:01UK RNSGSK PLC Julie Brown - External Appointment
19/2/202409:30UK RNSGSK PLC Director/PDMR Shareholding
15/2/202409:32UK RNSGSK PLC Director/PDMR Shareholding
15/2/202402:49ALNCNewsGSK completes USD1.4 billion purchase of respiratory firm..
15/2/202401:00UK RNSGSK PLC GSK completes acquisition of Aiolos Bio
13/2/202410:45UK RNSGSK PLC Director/PDMR Shareholding - Replacement
13/2/202409:40UK RNSGSK PLC Director/PDMR Shareholding
13/2/202409:35UK RNSGSK PLC Director/PDMR Shareholding
13/2/202409:30UK RNSGSK PLC Director/PDMR Shareholding
13/2/202402:25ALNCNewsIN THE KNOW: Citi turns positive on GSK after seven years on..
12/2/202409:39UK RNSGSK PLC Director/PDMR Shareholding

Su Consulta Reciente

Delayed Upgrade Clock